Managing a common disorder in children: Atopic dermatitis

Journal of Pediatric Health Care

Volumn 17, Issue 2, 2003, Pages 84-88

  Cheigh, Nina H ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CETIRIZINE; COAL TAR; CORTICOSTEROID; DIPHENHYDRAMINE; DOXEPIN; HYDROXYZINE; IMMUNOSUPPRESSIVE AGENT; LACTAM DERIVATIVE; LORATADINE; PIMECROLIMUS; TSUKUBAENOLIDE; ANTIINFLAMMATORY AGENT; DERMATOLOGICAL AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; KERATOLYTIC AGENT;

ACNE; ALLERGENICITY; ATOPIC DERMATITIS; BREAST FEEDING; BREAST MILK; CHILD PSYCHIATRY; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT DERMATITIS; CREAM; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENCY; DRUG SAFETY; ENDOCRINE DISEASE; FAMILY HISTORY; GENETIC CORRELATION; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HUMAN; HYDRATION; HYGIENE; MEDICAL PRACTICE; META ANALYSIS; OINTMENT; PATHOPHYSIOLOGY; PATIENT EDUCATION; PIGMENT DISORDER; PRURITUS; REVIEW; RISK ASSESSMENT; SEASONAL VARIATION; SIDE EFFECT; SKIN ATROPHY; SKIN BURNING SENSATION; SKIN CARE; SKIN MANIFESTATION; SKIN PROTECTION; STRIA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; BANDAGE; CHILD; METHODOLOGY; NURSING; RISK FACTOR; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; BANDAGES; CHILD; COAL TAR; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; HISTAMINE H1 ANTAGONISTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOLYTIC AGENTS; PATIENT EDUCATION; RISK FACTORS; SKIN CARE;

EID: 0347386496     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1067/mph.2003.38     Document Type: Article

References (39)

1. Beltrani, V.S. (1999). Managing atopic dermatitis. Dermatology Nursing, 11, 171-176, 179-185.
2. Berth-Jones J., Graham-Brown R.A.C. (1989). Failure of terfenadine in relieving the pruritus of atopic dermatitis. British Journal of Dermatology, 121, 635-637.
3. Bleiker T.O., Shahidullah H., Dutton E., Graham-Brown R.A. (2000). The prevalence and incidence of atopic dermatitis in a birth cohort: the importance of a family history of atopy. Archives of Dermatology, 136, 274-275.
4. Boguniewicz M., Fiedler V.C., Raimer S., Lawrence I.D., Leung D.Y., Hanifin J.M. (1998). A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Journal of Allergy and Clinical Immunology, 102, 637-644.
5. th AAD, New Orleans, LA 2002 Feb 23-27.
6. Diaz-Sanchez, D. (2000). Pollution and the immune response: atopic diseases-are we too dirty or too clean? Immunology, 101, 11-18.
7. Drake, L., Prendergast, M. (2001). The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. Journal of American Academy of Dermatology, 44, S65-72.
8. Drake, L.A., Dinehart, S.M. (1996). Guidelines of care for the use of topical glucocorticosteroids. Journal of American Academy of Dermatology, 35, 615-619.
9. Eigenmann, P.A. (2001). Clinical features and diagnostic criteria of atopic dermatitis in relation to age. Pediatric Allergy and Immmunology, 12 (suppl 14), 69-74.
10. Gdalevich, M., Mimouni, D., David, M., Mimouni, M. (2001). Breast-feeding and the onset of atopic dermatitis in childhood: a systematic review and meta-analysis of prospective studies. Journal of American Academy of Dermatology, 45, 520-527.
11. Halken, S., Host, A. (2000). The lessons of noninterventional and interventional prospective studies on the development of atopic disease during childhood. Allergy, 55, 793-802.
12. Hanifin, J.M. and Tofte, S.J. (1999). Update on therapy of atopic dermatitis. Journal of Allergy and Clinical Immunology, 104 (3, Pt.2), S123-127.
13. Hanifin, J.M., Rajka, G. (1980). Diagnostic features of atopic dermatitis. Acta Dermato-Venereologica, 92, 44-47.
14. Ho, V., Halbert, A., Takaoka, R. (2001). Pimecrolimus cream 1% is effective and safe in infants aged 3-23 months with atopic dermatitis. Journal of the European Academy of Dermatology and Venereology, 15 (Suppl2), S110.
15. Howlett, S. (1999). Emotional dysfunction, child-family relationships and childhood atopic dermatitis. British Journal of Dermatology, 140, 381-384.
16. Kang, S., Lucky, A.W., Pariser, D., Lawrence, I., Hanifin, J.M. (2001). Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. Journal of American Academy of Dermatology, 44, S58-64.
17. Kapp, A., Bingham, A. (2001). Pimecrolimus cream 1%: a new approach to long-term management of atopic dermatitis in infants 3 to 23 months of age. Journal of the European Academy of Dermatology and Venereology, 15 (Suppl2), S111.
18. Kemp, A.S. (1999). Atopic eczema: its social and financial costs. Journal of Paediatric Child Health, 35, 229-231.
19. Klein, P.A., Clark, R.A.F. (1999). An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Archives of Dermatology, 135, 1522-1525.
20. Koblenzer, C.S., Koblenzer, P.K. (1988). Chronic intractable atopic eczema: its occurrence as a physical sign of impaired parent-child relationships and psychologic developmental arrest: improvement through parent insight and education. Archives of Dermatology, 124, 1673-1677.
21. Lapidus, C.S., Schwarz, D.F. (1993). Atopic dermatitis in children: Who cares? Who pays? Journal of American Academy of Dermatology, 28, 699-703.
22. Leung, D.Y.M., Hanifin, J.M., Charlesworth, E.N., Li, J.T., Bernstein, I.L., et al. (Work Group on Atopic Dermatitis). (1997). Disease management of atopic dermatitis: a practice parameter. Annals of Allergy Asthma & Immunology, 79, 197-209.
23. Leung, D.Y.M, Tharp, M., Boguniewicz, M. (1999). Atopic dermatitis. In: Freeberg IM, Eisen AZ et al, eds. Dermatology in general medicine (pp. 1464-80). New York: McGraw-Hill.
24. Leung, D.Y.M. (2000). Atopic dermatitis: New insights and opportunities for therapeutic intervention. Journal of Allergy and Clinical Immunology, 105, 860-876.
25. Lucky, A., Marshall, K., Bush, C. (2001). SDZ ASM 981 cream 1% is effective and safe in children and adolescents with atopic dermatitis. Clinical and Experimental Dermatology, 26, 214.
26. Ngheim, P., Pearson, G., Langley, R.G. (2002). Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. Journal of American Acdemy of Dermatology, 46, 228-41.
27. Paller, A., Eichenfield, L.F., Leung, D.Y.M., Stewart, D., Appell, M. (2001). A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. Journal of American Academy of Dermatology, 44, S47-S57.
28. Peters, J. (2000). Eczema. Nursing Standard, 14, 16, 49-55.
29. Piacquadio, D.J. (1996). Topical steroids in clinical practice: focus on fluticasone propionate. Cutis, 57 (suppl), 4-9.
30. Queille-Roussel, C., Paul, C., Duteil, L., Lefebvre, M.C., Rapatz, G., Zagula, M., Ortonne, J.P. (2001). The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. British Journal of Dermatology, 144, 507-13.
31. Raimer, S.S. (2000). Managing pediatric atopic dermatitis. Clinical Pediatrics, 39, 1-14.
32. Reid, P., Lewis-Jones, M.S. (1995). Sleep difficulties and their management in preschoolers with atopic eczema. Clinical and Experimental Dermatology, 20, 38-41.
33. Roth, H.L. (1964). The natural history of atopic dermatitis. Archives of Dermatology, 89, 209.
34. Stoughton, R.B. (1992). Vasoconstrictor assay-scientific application. In: Maibach HI, eds. Topical Corticosteroids (pp 42-53). Basel: Karger.
35. Su, J.C., Kemp, A.S., Varigos, G.A., Nolan, T.M. (1997). Atopic eczema: its impact on the family and financial cost. Archives of Disease in Childhood, 76, 159-162.
36. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. (1998). Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. Lancet, 351, 1225-1232.
37. Wahn, U., Molloy, S., Graeber, M. (2001). SDZ ASM 981 cream 1%: a new approach to long-term management of atopic dermatitis. Journal of Investigative Dermatology, 117, 533.
38. Wahn, U. (2001). Atopic dermatitis in infancy and childhood: an ongoing challenge. Pediatric Allergy and Immunology, 12 (suppl14), 60-61.
39. Werner, Y., Lindberg, M. (1985). Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Dermato-Venereologica, 65, 102-105.